Home›Articles›A two-part cord blood product and its conditional authorization in EuropeArticleA two-part cord blood product and its conditional authorization in EuropeArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnAllogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel, Drugs and Medicinal Substances Well-attested SourcesAllogeneic umbilical cord-derived CD34- cells, non-expanded/dorocubicel (Wikipedia)Legal statusQuote, Legal statusIn June 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a conditional marketing authorization for the medicinal product ZemcelproView the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.